Methods of preventing or treating disorders by administering an integrin alphavbeta3 antagonist in combination with an HMG-CoA reductase inhibitor or a bisphosphonate

Details for Australian Patent Application No. 2003213682 (hide)

International Classifications

Event Publications

31 July 2003 Complete Application Filed

Priority application(s): 60/361,859 04.03.02 US; 60/444,156 30.01.03 US; 60/370,398 05.04.02 US; 60/444,265 30.01.03 US

30 October 2003 Application Open to Public Inspection

Published as AU-B-2003213682

20 September 2007 Application Accepted

Published as AU-B-2003213682

13 December 2007 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 18 Oct 2007. Address for service in Australia - Phillips Ormonde & Fitzpatrick Level 22 367 Collins Street Melbourne VIC 3000 2004

28 February 2008 Standard Patent Sealed

12 June 2008 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 18 Oct 2007

2 October 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.